Source comparison
Best CJC-1295 No DAC & Ipamorelin for Recovery: Comparison Table
This table compares recovery-relevant characteristics across peptide formulations commonly researched for tissue repair and regeneration. CJC-1295 no DAC + Ipamorelin GHRH analog + ghrelin mimetic. Synergistic pulsatile GH release 30 min / 2 hrs. Dosed 2–3× da
This comparison does not assign a generated winner or score.
- This table compares recovery-relevant characteristics across peptide formulations commonly researched for tissue repair and regeneration.
- CJC-1295 no DAC + Ipamorelin
- GHRH analog + ghrelin mimetic. Synergistic pulsatile GH release
- 30 min / 2 hrs. Dosed 2–3× daily
- GHRH-R and GHS-R1a. No cortisol or prolactin elevation
- High. Truncated sequences reduce peak GH by 25–30% at 90% purity
- Optimal for recovery. Pulsatile dynamics prevent receptor desensitization while maximizing tissue-level IGF-1
- CJC-1295 with DAC + Ipamorelin
- GHRH analog with albumin binding + ghrelin mimetic. Sustained GH elevation
- 6–8 days / 2 hrs. Dosed weekly + daily
- GHRH-R and GHS-R1a. Prolonged occupancy risks receptor downregulation
- Moderate. Long half-life masks purity issues initially but receptor saturation limits long-term benefit
- Suboptimal. Sustained receptor occupancy reduces GH response 40–60% by week 3
- Ipamorelin + GHRP-2
- Dual ghrelin mimetics. Amplified GH secretion but no GHRH component
- 2 hrs / 30 min. Dosed 3× daily
- GHS-R1a. GHRP-2 non-selective, elevates cortisol 15–25%
- Moderate. GHRP-2 stability issues cause oxidation that reduces potency in reconstituted solution
- Mixed. Strong GH response but cortisol elevation impairs collagen synthesis; not ideal for injury recovery
- Sermorelin + Ipamorelin
- Natural GHRH (1-29) + ghrelin mimetic. Physiological pulsatile GH
- 5–10 min / 2 hrs. Dosed 2–3× daily
- GHRH-R and GHS-R1a. Sermorelin rapidly degraded by DPP-IV enzyme
- Low. Sermorelin's short half-life makes purity less critical but also reduces practical efficacy
- Physiological but inefficient. Sermorelin's <10 min half-life requires immediate post-reconstitution use; CJC-1295 no DAC preferred
- Tesamorelin + Ipamorelin
- Synthetic GHRH analog (stabilized) + ghrelin mimetic. Approved for lipodystrophy
- 26 min / 2 hrs. Dosed 2× daily
- GHRH-R and GHS-R1a. Similar mechanism to CJC-1295 no DAC
- High. Prescription-grade purity standard (>98%) required; impurities cause injection-site reactions
- Comparable efficacy to CJC-1295 no DAC for recovery but higher cost and prescription requirement limit research use